Literature DB >> 11336589

Moxifloxacin: a review of the microbiological, pharmacological, clinical and safety features.

J M Blondeau1, G T Hansen.   

Abstract

Antimicrobial agents are used to treat patients with infectious diseases. Initial antimicrobial compounds originated from natural sources and were generally deemed to be narrow in spectrum. Today, we are in the era of designer drugs that have been specifically developed with current issues in infectious diseases in mind. For example, some new compounds require once daily dosing, have minimal side effects, are active against resistant pathogens and, for some, have a lower propensity for selecting for antimicrobial resistance during patient therapy.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336589     DOI: 10.1517/14656566.2.2.317

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  [New antimicrobial drugs: an update].

Authors:  Heinz Burgmann
Journal:  Wien Med Wochenschr       Date:  2003

2.  Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous Moxifloxacin in Pediatric Patients: Dose Optimization in a Phase 1 Study.

Authors:  Heino Stass; John Lettieri; Konstantina M Vanevski; Stefan Willmann; Laura P James; Janice E Sullivan; Antonio C Arrieta; John S Bradley
Journal:  J Clin Pharmacol       Date:  2019-01-25       Impact factor: 2.860

3.  Relative effectiveness of azithromycin in killing intracellular Porphyromonas gingivalis.

Authors:  Pin-Chuang Lai; John D Walters
Journal:  Clin Exp Dent Res       Date:  2016-02-05

4.  Targeted delivery of antibiotics to the infected pulmonary tissues using ROS-responsive nanoparticles.

Authors:  Yu Wang; Qian Yuan; Wei Feng; Wendan Pu; Jun Ding; Hongjun Zhang; Xiaoyu Li; Bo Yang; Qing Dai; Lin Cheng; Jinyu Wang; Fengjun Sun; Dinglin Zhang
Journal:  J Nanobiotechnology       Date:  2019-10-03       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.